Related Experiment Videos
Chronic mucocutaneous candidiasis revisited
A G Palma-Carlos1, M L Palma-Carlos
1Clinica Universitária de Medicina I, CHIUL-Center for Hematology and Immunology-Faculty of Medecine, Lisbon University and Clinical Allergology and Immunology Center, Lisbon, Portugal.
Allergie Et Immunologie
|August 17, 2001
Summary
This study investigated recurrent candidial infections in women, finding immune system defects in many patients. Treatment with Candida vaccines showed promising clinical results for most individuals.
Area of Science:
- Immunology
- Mycology
Background:
- Recurrent candidial infections pose a significant health challenge.
- Understanding the underlying immunological factors is crucial for effective treatment.
Purpose of the Study:
- To investigate immune responses in patients with recurrent candidial infections.
- To evaluate the efficacy of Candida vaccines in treating these infections.
Main Methods:
- Studied 26 female patients with recurrent candidial infections.
- Assessed delayed hypersensitivity to Candida antigens.
- Evaluated Natural Killer (NK) cell function.
- Monitored clinical outcomes after Candida vaccine treatment.
Main Results:
- Delayed hypersensitivity was observed in 17 out of 26 patients.
- 18 out of 23 patients (78%) exhibited a defect in NK cells.
- 11 of the first 13 treated patients showed good clinical improvement after vaccination.
Conclusions:
- Patients with recurrent candidial infections often present with immunological defects, including impaired NK cell function.
- Candida vaccines appear to be an effective therapeutic option for managing these infections.